Showing results (1581-1590 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|March 13, 2024
Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled TrialJon E Grant, Corine Driessens, Samuel R ChamberlainClinical Neuropharmacology|November 14, 2023
The Utility of Methylphenidate for Fatigue in Long-Term Neurological Conditions: A Meta-analytical ReviewAlexander James Hagan, Ram KumarClinical Neuropharmacology|July 15, 2024
Abelson Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review, Meta-analysis, and Meta-regressionGiovanni Gosch Berton, Amanda Cyntia Lima Fonseca Rodrigues, Rafael Dos Santos Borges, et al.Clinical Neuropharmacology|September 25, 2023
Three Cases of Myoclonus Secondary to Ciprofloxacin: "Ciproclonus"Hamna Javed, Hossam Tharwat Ali, Ziad Ashraf Soliman, et al.Clinical Neuropharmacology|September 25, 2023
Effects of Amantadine Sulfate on Motor Impairment and Execution of Motor Sequences in Patients With Parkinson DiseaseThomas Müller, Wilfried KuhnClinical Neuropharmacology|June 19, 2023
Aripiprazole-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case StudyChristian J Coulson, Marie Yrastorza-DaghmanClinical Neuropharmacology|June 19, 2023
Botulinum Toxins and Zinc: From Theory to Practice-A Systematic ReviewFarid Mallat, Jerome Kaikati, Elio KechichianClinical Neuropharmacology|June 19, 2023
Inflammation Markers Among Schizophrenia Patients Who Use CannabisJonathan Fridman, Esther Bloemhof-Bris, Shira Weizman, et al.Clinical Neuropharmacology|March 15, 2018
A Randomized Trial of Oral and Transdermal Rivastigmine for Postural Instability in Parkinson Disease DementiaJaime McDonald, Emmanuelle Pourcher, Alexandra Nadeau, et al.Clinical Neuropharmacology|January 17, 2019
Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson DiseaseCarolina C Ramírez-Gómez, Carlos Zúñiga-Ramírez, María Laura Contartese, et al.Pageof 237